AbbVie (ABBV) closed at $35.12 yesterday after opening at $34.40 following its spin-off from...

|About: AbbVie Inc. (ABBV)|By:, SA News Editor

AbbVie (ABBV) closed at $35.12 yesterday after opening at $34.40 following its spin-off from Abbott Labs (ABT), giving it a market cap of $55.8B vs Abbott's $50.7B. AbbVie faces plenty of challenges, not least reducing its dependence on its $9B-per-year arthritis treatment Humira, which accounts for at least 70% of the company's profit but which will lose its patent protection in 2017.